AVCN.TO
Avicanna Inc
Price:  
0.18 
CAD
Volume:  
136,438.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

-
Upside

As of 2026-03-15, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -13.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 21.53 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -1.63 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.18 CAD
Stock Price
- CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-13 -13.23
2026-03-12 -13.62
2026-03-11 -13.62
2026-03-10 -14.00
2026-03-09 -14.00
2026-03-06 -14.00
2026-03-05 -14.00
2026-03-04 -14.00
2026-03-03 -14.39
2026-03-02 -14.00
2026-02-27 -13.62
2026-02-26 -13.62
2026-02-25 -13.23
2026-02-24 -12.84
2026-02-20 -12.84
2026-02-19 -12.84
2026-02-18 -12.84
2026-02-17 -13.62
2026-02-13 -12.84
2026-02-12 -12.46
2026-02-11 -13.23
2026-02-10 -13.62
2026-02-09 -12.84
2026-02-06 -13.62
2026-02-05 -14.39
2026-02-04 -14.00
2026-02-03 -14.77
2026-02-02 -14.39
2026-01-30 -15.55
2026-01-29 -14.77
2026-01-28 -15.55
2026-01-27 -15.55
2026-01-26 -15.93
2026-01-23 -16.71
2026-01-22 -17.48
2026-01-21 -16.71
2026-01-20 -16.71
2026-01-19 -16.71
2026-01-16 -16.71
2026-01-15 -16.71
2026-01-14 -17.48
2026-01-13 -17.48
2026-01-12 -17.48
2026-01-09 -17.48
2026-01-08 -17.09
2026-01-07 -16.71
2026-01-06 -17.09
2026-01-05 -17.48
2026-01-02 -16.71
2025-12-30 -17.09